GSK plc GSK
NYSE GSK
$50.32 -0.09 (-0.18%)
At close: Nov 6, 2026 · 4:00 PM EST

Gsk (GSK) Liabilities from Discontinued Operations (2022 - 2025)

Updated

Gsk's Liabilities from Discontinued Operations came in at -$187.19 million for the quarter ended Dec 31, 2025.

Analysis

Gsk (GSK) Liabilities from Discontinued Operations (2022 - 2025) Analysis & Trends

  • The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Liabilities from Discontinued Operations since the quarter ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Gsk 102.08 Bn 84.92 Bn 8.73 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -187.19 Mn
Jun 30, 2022 -21.66 Bn
API Access

Gsk Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=GSK&period=max&api_key=YOUR_API_KEY